| Primary |
| Benign Prostatic Hyperplasia |
46.2% |
| Hypertension |
13.3% |
| Blood Cholesterol Increased |
6.7% |
| Prostatomegaly |
6.0% |
| Pollakiuria |
3.8% |
| Diabetes Mellitus |
2.7% |
| Dysuria |
2.3% |
| Prostate Cancer |
2.2% |
| Cardiac Disorder |
1.9% |
| Prophylaxis |
1.6% |
| Urine Flow Decreased |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Atrial Fibrillation |
1.5% |
| Urinary Retention |
1.5% |
| Prostatic Disorder |
1.5% |
| Nocturia |
1.3% |
| Nephrolithiasis |
1.3% |
| Urinary Tract Disorder |
1.1% |
| Blood Pressure Increased |
1.0% |
| Depression |
0.9% |
|
| Drug Ineffective |
20.4% |
| Nocturia |
10.7% |
| Dizziness |
6.8% |
| Semen Volume Decreased |
6.4% |
| Syncope |
5.8% |
| Vision Blurred |
5.5% |
| Pollakiuria |
5.4% |
| Rhinorrhoea |
5.0% |
| Urine Flow Decreased |
3.6% |
| Urinary Incontinence |
3.5% |
| Ejaculation Failure |
3.3% |
| Urinary Retention |
3.1% |
| Retrograde Ejaculation |
2.9% |
| Nasal Congestion |
2.8% |
| Loss Of Consciousness |
2.6% |
| Somnolence |
2.6% |
| Rash |
2.5% |
| Hypotension |
2.5% |
| Erectile Dysfunction |
2.4% |
| Prostate Cancer |
2.3% |
|
| Secondary |
| Benign Prostatic Hyperplasia |
30.3% |
| Hypertension |
11.1% |
| Prostatomegaly |
7.4% |
| Drug Use For Unknown Indication |
5.8% |
| Pollakiuria |
5.5% |
| Blood Cholesterol Increased |
5.5% |
| Dysuria |
4.5% |
| Product Used For Unknown Indication |
3.4% |
| Cardiac Disorder |
3.0% |
| Urinary Retention |
2.7% |
| Urine Flow Decreased |
2.7% |
| Nocturia |
2.5% |
| Prostatic Disorder |
2.5% |
| Prostate Cancer |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Prostatitis |
1.9% |
| Blood Pressure |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Micturition Urgency |
1.6% |
| Prophylaxis |
1.5% |
|
| Drug Ineffective |
13.3% |
| Nocturia |
10.8% |
| Pollakiuria |
8.0% |
| Syncope |
8.0% |
| Vision Blurred |
7.8% |
| Urinary Incontinence |
5.3% |
| Semen Volume Decreased |
4.8% |
| Urine Flow Decreased |
4.8% |
| Urinary Retention |
4.3% |
| Dizziness |
3.8% |
| Rash |
3.5% |
| Rhinorrhoea |
3.5% |
| Priapism |
3.0% |
| Urticaria |
3.0% |
| Visual Acuity Reduced |
3.0% |
| Retrograde Ejaculation |
2.8% |
| Urine Output Decreased |
2.8% |
| Vertigo |
2.8% |
| Urinary Tract Infection |
2.5% |
| Fatigue |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.7% |
| Drug Use For Unknown Indication |
19.4% |
| Hypertension |
7.1% |
| Pain |
4.3% |
| Multiple Myeloma |
4.2% |
| Benign Prostatic Hyperplasia |
3.9% |
| Diabetes Mellitus |
3.1% |
| Atrial Fibrillation |
2.7% |
| Blood Cholesterol Increased |
2.6% |
| Prostate Cancer |
2.6% |
| Prophylaxis |
2.3% |
| Rheumatoid Arthritis |
2.3% |
| Depression |
2.2% |
| Multiple Sclerosis |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Asthma |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Type 2 Diabetes Mellitus |
1.7% |
| Prostatomegaly |
1.6% |
| Prostatic Disorder |
1.5% |
|
| Weight Decreased |
12.7% |
| Vomiting |
9.0% |
| Weight Increased |
7.2% |
| Drug Ineffective |
6.8% |
| Death |
6.0% |
| Urinary Tract Infection |
5.7% |
| Pneumonia |
5.3% |
| Flushing |
4.4% |
| Rash |
4.3% |
| Pain |
4.2% |
| Vision Blurred |
4.0% |
| Myocardial Infarction |
4.0% |
| Pyrexia |
3.8% |
| Dyspnoea |
3.6% |
| Pruritus |
3.4% |
| Urinary Retention |
3.3% |
| Syncope |
3.2% |
| Wrong Technique In Drug Usage Process |
3.1% |
| Renal Failure Acute |
3.0% |
| Thrombocytopenia |
2.8% |
|
| Interacting |
| Micturition Disorder |
27.9% |
| Drug Use For Unknown Indication |
18.6% |
| Type 2 Diabetes Mellitus |
18.6% |
| Prostatic Disorder |
9.3% |
| Benign Prostatic Hyperplasia |
7.0% |
| Cardiac Fibrillation |
7.0% |
| Erectile Dysfunction |
2.3% |
| Heart Rate Irregular |
2.3% |
| Hypertension |
2.3% |
| Prostate Infection |
2.3% |
| Prostatitis |
2.3% |
|
| Drug Interaction |
31.3% |
| Urinary Retention |
18.8% |
| Epistaxis |
12.5% |
| Pain |
12.5% |
| Tongue Carcinoma Stage Iv |
12.5% |
| Heart Rate Decreased |
6.3% |
| Prostate Infection |
6.3% |
|
